Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 8680111 Macrocyclic derivatives for the treatment of diseases

Patent 8680111 was granted and assigned to Pfizer Limited on March, 2014 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Patent Applicant

Current Assignee

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

8680111

Patent Inventor Names

Robert Louis Hoffman0

Robert Steven Kania0

Simon Bailey0

Ted William Johnson0

Judith Gail Deal0

Benjamin Joseph Burke0

Cynthia Louise Palmer0

Jingrong Jean Cui0

...

Date of Patent

March 25, 2014

Patent Application Number

13786106

Date Filed

March 5, 2013

Patent Citations Received

‌

US Patent 11667649 Heteroaromatic macrocyclic ether chemotherapeutic agents

‌

US Patent 11981684 Macrocyclic compounds and uses thereof

‌

US Patent 11926636 Crystalline forms of lorlatinib maleate

Patent Primary Examiner

‌

Sarah Pihonak

Patent abstract

The invention relates to compounds of formula (Φ)

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 8680111 Macrocyclic derivatives for the treatment of diseases

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API